Orexo
Develops pharmaceuticals & digital health for opioid use disorder in the US market.
ORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000736415 (+2 more)
- LEI:
- 549300LJ5CCWDPTK9Z08
- Country:
- Sweden
- Address:
- Box 303, 751 05 UPPSALA
- Website:
- https://orexo.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Orexo is an international, commercial-stage pharmaceutical company specializing in the development of improved pharmaceuticals based on proprietary drug delivery technologies. With a 30-year history, the company creates innovative treatment solutions for significant medical needs. A primary focus for Orexo is the US market, where it commercializes drugs and digital mental health programs for patients suffering from opioid use disorder (OUD) and adjacent diseases. Through its robust product pipeline, Orexo is committed to addressing major public health challenges, including the opioid crisis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-13 20:30 |
Orexo successfully issues senior secured callable floating rate social bonds of…
|
English | 198.5 KB | ||
| 2024-03-13 20:30 |
Orexo har framgångsrikt emitterat seniora säkerställda sociala obligationer med…
|
Swedish | 199.2 KB | ||
| 2024-02-08 08:01 | Swedish | 4.8 MB | |||
| 2024-02-08 08:01 | English | 4.8 MB | |||
| 2023-11-02 08:00 | Swedish | 2.6 MB | |||
| 2023-11-02 08:00 | English | 2.9 MB | |||
| 2023-10-26 16:05 |
Kommuniké från Orexo:s extra bolagsstämma
|
Swedish | 117.6 KB | ||
| 2023-10-26 16:05 |
Report from Orexo´s extraordinary general meeting
|
English | 120.7 KB | ||
| 2023-10-11 08:00 |
Orexo offentliggör data från MODIA-studien som utvärderar effekten på användnin…
|
Swedish | 249.5 KB | ||
| 2023-10-11 08:00 |
Orexo announces data from the MODIA® study evaluating impact on use of illicit …
|
English | 236.3 KB | ||
| 2023-10-02 18:30 |
Notice of Extraordinary General Meeting in Orexo AB (publ)
|
English | 198.3 KB | ||
| 2023-10-02 18:30 |
Kallelse till extra bolagsstämma i Orexo AB (publ)
|
Swedish | 200.2 KB | ||
| 2023-07-18 08:00 | Swedish | 4.0 MB | |||
| 2023-07-18 08:00 | English | 4.0 MB | |||
| 2023-07-01 11:20 |
Orexo wins patent litigation for ZUBSOLV® in the US
|
English | 132.2 KB |
Automate Your Workflow. Get a real-time feed of all Orexo filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orexo
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orexo via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-11 | Nikolaj Arrild Sørensen | Other | Buy | 2,460 | 35,178.00 SEK |
| 2025-04-04 | Nikolaj Arrild Sørensen | Other | Buy | 3,500 | 47,530.00 SEK |
| 2024-03-26 | Fredrik Järrsten | Other | Buy | 3,000 | 44,040.00 SEK |
| 2023-11-24 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 44,640.00 SEK |
| 2023-11-08 | Fredrik Järrsten | Other | Buy | 1,500 | 23,715.00 SEK |
| 2023-02-24 | Nikolaj Arrild Sørensen | Other | Buy | 11,500 | 188,945.00 SEK |
| 2023-01-27 | Fredrik Järrsten | Other | Buy | 4,500 | 79,695.00 SEK |
| 2022-07-26 | Michael Matly | Other | Buy | 2,820 | 60,777.77 SEK |
| 2022-07-21 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 61,500.00 SEK |
| 2022-07-15 | James Noble | Other | Buy | 18,500 | 394,252.80 SEK |
Peer Companies
